Document Metadata
Conference Call Details
Date: Wednesday, November 4, 2026
Time: 6:00 P.M. IST
Purpose: To discuss the financial and operating performance for Q2 & H1 FY27
Management Participants
The conference call will feature the following management representatives:
- (Hony) Brig. Dr. Arvind Lal – Executive Chairman
- Mr. Shankha Banerjee – Chief Executive Officer
- Mr. Ved Prakash Goel – Group Chief Financial Officer & CEO – International Business
Call Structure
The conference call will begin with a brief discussion by management on Q2 & H1 FY27 financial and operating performance, which will be announced on the same day. Following the management presentation, there will be a question-and-answer session for participants.
Registration and Access Information
Pre-registration: Required via provided link to receive dial-in numbers, passcode, and pin
Universal Access Numbers: +91 22 6280 1141, +91 22 7115 8042
International Toll Numbers:
- USA: 18667462133
- UK: 08081011573
- Singapore: 8001012045
- Hong Kong: 800964448
Company Background Information
Dr. Lal PathLabs Limited is described as one of India's leading consumer healthcare brands in diagnostic services with an integrated nationwide network. As of March 31, 2026, the company offers:
- 525 test panels
- 3,130 pathology tests
- 1,173 radiology and cardiology tests
Operational Network (as of March 31, 2026)
- 312 clinical labs (including National Reference Lab at Delhi & Regional Reference Labs at Kolkata, Bangalore & Mumbai)
- 7,727 Patient Service Centers (PSCs)
- 13,935 Pick-up Points (PUPs)
Volume Statistics
- FY26: Processed approximately 94.5 million samples from 30.3 million patients
- FY25: Processed approximately 85.6 million samples from 28.8 million patients
Disclaimer Note
The document includes a standard disclaimer noting that certain statements made during the conference call may be forward-looking statements subject to risks and uncertainties including government actions, local political or economic developments, and technological risks.